Your browser doesn't support javascript.
loading
Development of a Multicompartment Permeability-Limited Lung PBPK Model and Its Application in Predicting Pulmonary Pharmacokinetics of Antituberculosis Drugs.
Gaohua, L; Wedagedera, J; Small, B G; Almond, L; Romero, K; Hermann, D; Hanna, D; Jamei, M; Gardner, I.
Affiliation
  • Gaohua L; Simcyp Limited (a Certara company) Sheffield, United Kingdom.
  • Wedagedera J; Simcyp Limited (a Certara company) Sheffield, United Kingdom.
  • Small BG; Simcyp Limited (a Certara company) Sheffield, United Kingdom.
  • Almond L; Simcyp Limited (a Certara company) Sheffield, United Kingdom.
  • Romero K; Critical Path Institute Tucson, Arizona, USA.
  • Hermann D; Certara USA, Inc. Princeton, New Jersey, USA.
  • Hanna D; Critical Path Institute Tucson, Arizona, USA.
  • Jamei M; Simcyp Limited (a Certara company) Sheffield, United Kingdom.
  • Gardner I; Simcyp Limited (a Certara company) Sheffield, United Kingdom.
CPT Pharmacometrics Syst Pharmacol ; 4(10): 605-13, 2015 Oct.
Article in En | MEDLINE | ID: mdl-26535161
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2015 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2015 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos